| Year |
Citation |
Score |
| 2017 |
Crane A, Brubaker WD, Johansson JU, Trigunaite A, Ceballos J, Bradt B, Glavis-Bloom C, Wallace TL, Tenner AJ, Rogers J. Peripheral complement interactions with amyloid β peptide in Alzheimer's disease: 2. Relationship to Aβ immunotherapy. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28755839 DOI: 10.1016/J.Jalz.2017.04.015 |
0.663 |
|
| 2017 |
Brubaker WD, Crane A, Johansson JU, Yen K, Garfinkel K, Mastroeni D, Asok P, Bradt B, Sabbagh M, Wallace TL, Glavis-Bloom C, Tenner AJ, Rogers J. Peripheral complement interactions with amyloid β peptides in Alzheimer's disease: Erythrocyte clearance of amyloid β peptides. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28475854 DOI: 10.1016/J.Jalz.2017.03.010 |
0.665 |
|
| 2015 |
Goonawardena AV, Heiss J, Glavis-Bloom C, Trube G, Borroni E, Alberati D, Wallace TL. Alterations in High-Frequency Neuronal Oscillations in a Cynomolgus Macaque Test of Sustained Attention Following NMDA Receptor Antagonism. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26354045 DOI: 10.1038/Npp.2015.281 |
0.649 |
|
| 2015 |
Wallace TL, Ballard TM, Glavis-Bloom C. Animal paradigms to assess cognition with translation to humans. Handbook of Experimental Pharmacology. 228: 27-57. PMID 25977079 DOI: 10.1007/978-3-319-16522-6_2 |
0.646 |
|
| 2005 |
Li YW, Fitzgerald L, Wong H, Lelas S, Zhang G, Lindner MD, Wallace T, McElroy J, Lodge NJ, Gilligan P, Zaczek R. The pharmacology of DMP696 and DMP904, non-peptidergic CRF1 receptor antagonists. Cns Drug Reviews. 11: 21-52. PMID 15867951 DOI: 10.1111/J.1527-3458.2005.Tb00034.X |
0.303 |
|
| 2003 |
Williams MT, Morford LL, Wood SL, Wallace TL, Fukumura M, Broening HW, Vorhees CV. Developmental D-methamphetamine treatment selectively induces spatial navigation impairments in reference memory in the Morris water maze while sparing working memory. Synapse (New York, N.Y.). 48: 138-48. PMID 12645039 DOI: 10.1002/Syn.10159 |
0.417 |
|
| 2003 |
Williams MT, Morford LL, Wood SL, Rock SL, McCrea AE, Fukumura M, Wallace TL, Broening HW, Moran MS, Vorhees CV. Developmental 3,4-methylenedioxymethamphetamine (MDMA) impairs sequential and spatial but not cued learning independent of growth, litter effects or injection stress. Brain Research. 968: 89-101. PMID 12644267 DOI: 10.1016/S0006-8993(02)04278-6 |
0.429 |
|
| 2003 |
Wallace TL, Vorhees CV, Zemlan FP, Gudelsky GA. Methamphetamine enhances the cleavage of the cytoskeletal protein tau in the rat brain. Neuroscience. 116: 1063-8. PMID 12617947 DOI: 10.1016/S0306-4522(02)00795-9 |
0.441 |
|
| 2001 |
Wallace TL, Gudelsky GA, Vorhees CV. Alterations in diurnal and nocturnal locomotor activity in rats treated with a monoamine-depleting regimen of methamphetamine or 3,4-methylenedioxymethamphetamine. Psychopharmacology. 153: 321-6. PMID 11271404 DOI: 10.1007/S002130000578 |
0.407 |
|
| 2001 |
Wallace TL, Vorhees CV, Gudelsky GA. Effects of lubeluzole on the methamphetamine-induced increase in extracellular glutamate and the long-term depletion of striatal dopamine. Synapse (New York, N.Y.). 40: 95-101. PMID 11252020 DOI: 10.1002/Syn.1030 |
0.406 |
|
| 2001 |
Wallace TL, Gudelsky GA, Vorhees CV. Neurotoxic regimen of methamphetamine produces evidence of behavioral sensitization in the rat. Synapse (New York, N.Y.). 39: 1-7. PMID 11071703 DOI: 10.1002/1098-2396(20010101)39:1<1::Aid-Syn1>3.0.Co;2-7 |
0.419 |
|
| 1999 |
Wallace TL, Gudelsky GA, Vorhees CV. Methamphetamine-induced neurotoxicity alters locomotor activity, stereotypic behavior, and stimulated dopamine release in the rat. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 9141-8. PMID 10516332 DOI: 10.1523/Jneurosci.19-20-09141.1999 |
0.423 |
|
| Show low-probability matches. |